← Back to list
Reimbursement Policy Updates
Act
by Jun 8, 2026
Effective date
Jun 8, 2026
Identified
Jun 24, 2026
Summary
Blue Cross Blue Shield of Texas updated 23 laboratory and diagnostic reimbursement policies effective between June 8, 2026 and September 4, 2026. These policies cover payment rules and methodologies for various laboratory tests including flow cytometry, biomarker testing, hormone testing, and cancer screening procedures.
Get alerts when payers change rules like this one
We check BCBS Texas and other payers every day and email you when a change matches your specialty and state.
Get BCBS Texas alertsPolicy Monitoring is free. No card required.
What to do
by Jun 8, 2026 · 3 steps
01Review and implement updated reimbursement policy RP039 for outpatient facility services overlapping during inpatient stays.
02By September 4, 2026: Billing team must review all 22 updated laboratory reimbursement policies (RPLAB001-RPLAB071) to understand new payment rules and coding requirements for procedures including flow cytometry, PSA testing, biomarker testing, allergen testing, hepatitis testing, thyroid testing, cardiovascular risk assessment, tumor markers, and various other laboratory services.
03Update billing software and staff training materials accordingly to ensure compliance with new reimbursement methodologies.
Original notice
Reimbursement Policy Updates
bcbstx.com · Always check the source before changing claims.
Related changes
See all BCBS Texas changes →Reimbursement Policy UpdatesMediumNo effective date · ReimbursementReimbursement Policy UpdatesHighNo effective date · ReimbursementReimbursement Policy UpdatesMediumNo effective date · ReimbursementReimbursement Policy UpdatesMediumNo effective date · ReimbursementBrowse every BCBS Texas change in the policy list